Core Viewpoint - Shineco, Inc. has initiated an underwritten public offering of its common stock and pre-funded warrants, with the offering subject to market conditions and no assurance of completion or specific terms [1]. Group 1: Offering Details - The offering includes shares of common stock and pre-funded warrants, all offered by the Company [1]. - The offering is conducted under an effective shelf registration statement on Form S-3, which was filed with the SEC and declared effective on June 10, 2022 [2]. - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC, detailing the terms of the public offering [2][3]. Group 2: Company Overview - Shineco, Inc. focuses on providing safe, efficient, and high-quality health and medical products and services, aiming to improve the quality of life [5]. - The Company has developed 33 vitro diagnostic reagents and related medical devices and also produces and sells healthy and nutritious foods [5].
Shineco Announces Proposed Underwritten Public Offering